SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
初丹
Lv4
640 积分
2023-04-22 加入
最近求助
最近应助
互助留言
The changing landscape of atherosclerosis
10天前
已完结
Clinical Implications of Conversion Surgery After Induction Therapy for T4b Thoracic Esophageal Squamous Cell Carcinoma
2个月前
已完结
Multicenter Randomized Phase 2 Trial Comparing Chemoradiotherapy and Docetaxel Plus 5-Fluorouracil and Cisplatin Chemotherapy as Initial Induction Therapy for Subsequent Conversion Surgery in Patients With Clinical T4b Esophageal Cancer: Short-term Results
2个月前
已完结
Surgical Treatment of Lung Cancer
2个月前
已完结
Lung Cancer Treatment Advances in 2022
2个月前
已完结
Characteristics Predicting Short-Term and Long-Term Health-Related Quality of Life in Patients with Esophageal Cancer After Neoadjuvant Chemoradiotherapy and Esophagectomy
3个月前
已完结
Intraoperative Blood Loss Impacts Recurrence and Survival in Patients With Locally Advanced Esophageal Cancer
3个月前
已关闭
Intraoperative Blood Loss Impacts Recurrence and Survival in Patients With Locally Advanced Esophageal Cancer
3个月前
已关闭
PACLITAXEL PLUS CISPLATTN AND 5 FUOROURACTL INDUCTION CHEMOTHERAPY FOR BORDERLINE RESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA: 3-YEAR SURVIVAL RESULT
3个月前
已关闭
SINTILUVIAB PLUS CISPLATUN AND PACLITAXEL INDUCTION TREATMENT FOR BORDERLINE RESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A PHASE H CLINICAL TRIAL
3个月前
已关闭
没有进行任何应助
点赞,速度真快
3个月前
点赞
3个月前
标题不对
3个月前
标题错误
3个月前
文章不对
3个月前
速度真快
8个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论